Vaccine Advisers at the US Food and Drug Administration have voted to recommend authorizing the urgent use of a booster dose of Pfizer vaccine for over 65-year-olds and high-risk individuals with COVID-19, six months after injecting two doses. first, according to CNN.
However, the FDA’s Advisory Committee on Vaccines and Biological Products rejected a broader application for approval of the booster dose for all persons 16 years of age and older, six months after being fully vaccinated.
Some of the advisers, a group of vaccine experts, immunologists, pediatricians, infectious disease specialists and public health experts, said the process was rushed, while some members said during the meeting they wanted to see more data.
The group unanimously supported the authorization for the most limited group at higher risk and informally informed the FDA to include health care workers or others at high risk of exposure to COVID-19.
The FDA is now expected to draft its decision, at Pfizer’s request, taking into account the committee’s instructions.ATSH
To be part of the group »AOL“just click: Join Group and your request will be approved immediately.